
Apollo Hospitals Enterprise vs Fortis Healthcare: Which Stock Should You Track
Apollo Hospitals MCap Rs 1,28,277 Cr, PE 64.05x, ROE 20.48%, D/E 0.90. Fortis Healthcare MCap Rs 70,589 Cr, PE 66.31x, ROE 10.53%, D/E 0.35.
Updated: 6 Aug 2026 • 11:37 am
Posted by:

Apollo Hospitals Enterprise vs Fortis Healthcare is a comparison hospital chain investors look up when evaluating two of India's leading private hospital networks. Apollo Hospitals is India's largest integrated healthcare network with over 70 hospitals, pharmacies, diagnostics and digital health platforms, while Fortis Healthcare is owned by IHH Healthcare Berhad of Malaysia and operates over 30 hospitals across India.
This Apollo Hospitals Enterprise vs Fortis Healthcare article covers reach and market position, key products, latest declared results and stock valuation. The Apollo Hospitals Enterprise vs Fortis Healthcare data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Apollo Hospitals Enterprise vs Fortis Healthcare: Reach and Market Position
On the Apollo Hospitals Enterprise side of the Apollo Hospitals Enterprise vs Fortis Healthcare comparison, Apollo Hospitals operates over 70 hospitals across India, plus Apollo Pharmacy (over 5,000 stores), Apollo Diagnostics and Apollo HealthCo digital health platform. Market capitalisation is Rs 1,28,277 Cr.
Click Here – Get Free Investment Predictions
On the Fortis Healthcare side of the Apollo Hospitals Enterprise vs Fortis Healthcare comparison, Fortis Healthcare operates over 30 hospitals including SRL Diagnostics, with a presence in metro and major tier 2 cities. IHH Healthcare Malaysia owns a majority stake. Market capitalisation is Rs 70,589 Cr.
Apollo Hospitals Enterprise vs Fortis Healthcare: Key Products and Business Mix
In the Apollo Hospitals Enterprise vs Fortis Healthcare product comparison, Apollo Hospitals Enterprise offers: Apollo Hospitals earns from inpatient procedures, outpatient consultations, pharmacy and diagnostic revenues. P/E is 64.05x, ROE 20.48 percent, debt to equity 0.90.
For Fortis Healthcare in this Apollo Hospitals Enterprise vs Fortis Healthcare breakdown: Fortis Healthcare earns from inpatient and day care procedures and diagnostics through SRL. P/E is 66.31x, ROE 10.53 percent, debt to equity 0.35.
Apollo Hospitals Enterprise vs Fortis Healthcare: Latest Results
The Apollo Hospitals Enterprise vs Fortis Healthcare results for Apollo Hospitals Enterprise: Apollo Hospitals has a market cap of Rs 1,28,277 Cr and P/E of 64.05x. ROE is 20.48 percent. Apollo is nearly twice larger than Fortis by market cap.
The Apollo Hospitals Enterprise vs Fortis Healthcare results for Fortis Healthcare: Fortis Healthcare has a market cap of Rs 70,589 Cr and P/E of 66.31x. ROE is 10.53 percent, significantly lower than Apollo. EPS is Rs 14.10.
Compare Apollo Hospitals Enterprise and Fortis Healthcare Fundamentals on the Univest Screener
Apollo Hospitals Enterprise vs Fortis Healthcare: Stock and Valuation
The Apollo Hospitals Enterprise vs Fortis Healthcare stock comparison uses the latest available market data from Groww. Investors tracking Apollo Hospitals Enterprise vs Fortis Healthcare should verify current prices on NSE or BSE before trading.
Apollo Hospitals trades at a market cap of Rs 1,28,277 Cr and P/E of 64.05x with ROE of 20.48 percent. Fortis Healthcare trades at Rs 70,589 Cr market cap and P/E of 66.31x at a virtually identical P/E to Apollo, despite Apollo having nearly double the market cap and twice the ROE.
Apollo Hospitals Enterprise vs Fortis Healthcare: Quick Comparison Table
The Apollo Hospitals Enterprise vs Fortis Healthcare comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Apollo Hospitals Enterprise | Fortis Healthcare |
|---|---|---|
| Sector | Hospital chain, pharmacy, diagnostics, digital health | Hospital chain and diagnostics |
| Market Cap | Rs 1,28,277 Cr | Rs 70,589 Cr |
| P/E Ratio | 64.05x | 66.31x |
| ROE | 20.48% | 10.53% |
| Debt to Equity | 0.90 | 0.35 |
| Hospitals | 70-plus hospitals | 30-plus hospitals |
| Promoter | Prathap Reddy family | IHH Healthcare Malaysia |
Conclusion
The Apollo Hospitals Enterprise vs Fortis Healthcare comparison above covers the key data points on reach, products, results and valuation. Apollo Hospitals vs Fortis Healthcare are both leading private hospital chains trading at similar high P/E multiples. Apollo Hospitals is larger and delivers twice the ROE at essentially the same P/E as Fortis. Fortis carries lower debt. Investors should review average revenue per occupied bed, occupancy rates and expansion pipeline and consult a SEBI-registered advisor before investing.
Download the Univest iOS App or Univest Android App to track Apollo Hospitals Enterprise and Fortis Healthcare live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the main difference between Apollo Hospitals and Fortis Healthcare?
Ans. Apollo Hospitals is India's largest healthcare network with 70-plus hospitals, pharmacies and diagnostics under the Apollo brand. Fortis Healthcare is a 30-plus hospital chain owned by IHH Healthcare Malaysia.
Which company has the higher ROE?
Ans. Apollo Hospitals has an ROE of 20.48 percent, almost double Fortis Healthcare at 10.53 percent.
Why do both hospitals trade at such high P/E multiples?
Ans. Hospitals invest heavily in capex for beds, equipment and facilities, creating depreciation charges that suppress current earnings relative to long-term cash-generating potential, resulting in high P/E multiples.
Which company has lower debt?
Ans. Fortis Healthcare has a debt to equity of 0.35, lower than Apollo Hospitals at 0.90.
Who owns Fortis Healthcare?
Ans. Fortis Healthcare is majority owned by IHH Healthcare Berhad, a Malaysian hospital group also owned by Khazanah Nasional (Malaysia) and Mitsui (Japan).
What risks apply to hospital chains?
Ans. Both face risk from doctor attrition, healthcare regulation changes, medical inflation affecting cost, and competition from other hospital chains.
Should I invest in Apollo or Fortis?
Ans. Apollo is larger with twice the ROE at the same P/E. Fortis has lower debt with IHH backing. Consult a SEBI-registered advisor before investing.
Recent Articles

Sun Pharma Advanced Research Company Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
6 August 2026

IDFC First Bank Share: Pros and Cons Every Investor Must Know in 2026
6 August 2026

Jammu and Kashmir Bank Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
6 August 2026

Tata Investment Corporation Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
6 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sun Pharma Advanced Research Company Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
IDFC First Bank Share: Pros and Cons Every Investor Must Know in 2026
Jammu and Kashmir Bank Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Tata Investment Corporation Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Muthoot Finance Share: Pros and Cons Every Investor Must Know in 2026
Popular this week
Sun Pharma Advanced Research Company Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
IDFC First Bank Share: Pros and Cons Every Investor Must Know in 2026
Jammu and Kashmir Bank Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Tata Investment Corporation Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Muthoot Finance Share: Pros and Cons Every Investor Must Know in 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





